The interleukin 22 pathway interacts with mutant KRAS to promote poor prognosis in colon cancer.
Purpose: The cytokine interleukin 22 (IL-22) promotes tumor progression in murine models of colorectal cancer (CRC). However, the clinical significance of IL-22 in human CRC remains unclear. We sought to determine whether the IL-22 pathway is associated with prognosis in human CRC, and to identify m...
| Հիմնական հեղինակներ: | , , , , , , , , , , , , , |
|---|---|
| Ձևաչափ: | Journal article |
| Լեզու: | English |
| Հրապարակվել է: |
American Association for Cancer Research
2020
|